BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19056253)

  • 1. Chemotherapy-induced recall of cetuximab and radiation skin reaction.
    Law AB; Junor EJ
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):77-8. PubMed ID: 19056253
    [No Abstract]   [Full Text] [Related]  

  • 2. Late onset of skin toxicity induced by EGFr-inhibitors.
    Eriksen JG; Overgaard M
    Radiother Oncol; 2009 Feb; 90(2):280-1. PubMed ID: 19010559
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe cutaneous reaction during radiation therapy with concurrent cetuximab.
    Budach W; Bölke E; Homey B
    N Engl J Med; 2007 Aug; 357(5):514-5. PubMed ID: 17671265
    [No Abstract]   [Full Text] [Related]  

  • 4. A docetaxel-induced rash on a radiotherapy port.
    Quatresooz P; Piérard GE
    Am J Clin Dermatol; 2010; 11(5):367-9. PubMed ID: 20504047
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxidative damage and cutaneous reactions during radiotherapy in combination with cetuximab.
    Skvortsova I
    Radiother Oncol; 2009 Feb; 90(2):281-2. PubMed ID: 19150740
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe desquamation with skin necrosis: a distinct pattern of skin toxicity secondary to head and neck irradiation with concomitant cetuximab.
    Billan S; Abdah-Bortnyak R; Kuten A
    Isr Med Assoc J; 2008 Mar; 10(3):247. PubMed ID: 18494248
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypofractionated radiotherapy plus cetuximab in locally advanced head and neck cancer.
    Teoh DC; Rodger S; Say J; Hartley A
    Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):717. PubMed ID: 18757187
    [No Abstract]   [Full Text] [Related]  

  • 8. Subcutaneous abscess as a side-effect of cetuximab therapy.
    Guerriero C; Ricci F; Paradisi A; Fossati B; Valentini V; Pacelli F; Capizzi R
    Eur J Dermatol; 2011; 21(2):277-8. PubMed ID: 21382780
    [No Abstract]   [Full Text] [Related]  

  • 9. High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes.
    Giro C; Berger B; Bölke E; Ciernik IF; Duprez F; Locati L; Maillard S; Ozsahin M; Pfeffer R; Robertson AG; Langendijk JA; Budach W
    Radiother Oncol; 2009 Feb; 90(2):166-71. PubMed ID: 18977050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer.
    Pryor DI; Porceddu SV; Burmeister BH; Guminski A; Thomson DB; Shepherdson K; Poulsen M
    Radiother Oncol; 2009 Feb; 90(2):172-6. PubMed ID: 18976827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trastuzumab-induced radiation recall dermatitis--first reported case.
    Shrimali RK; McPhail NJ; Correa PD; Fraser J; Rizwanullah M
    Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):634-5. PubMed ID: 19372036
    [No Abstract]   [Full Text] [Related]  

  • 12. Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRT.
    Studer G; Brown M; Salgueiro EB; Schmückle H; Romancuk N; Winkler G; Lee SJ; Sträuli A; Kissling B; Dummer R; Glanzmann C
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):110-7. PubMed ID: 20732757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acneiform rash secondary to cetuximab plus head and neck radiotherapy.
    Mydin AR; Armstrong JG
    Radiother Oncol; 2007 Oct; 85(1):171. PubMed ID: 17531339
    [No Abstract]   [Full Text] [Related]  

  • 14. More on severe cutaneous reaction with radiotherapy and cetuximab.
    Bonner JA; Ang K
    N Engl J Med; 2007 Nov; 357(18):1872-3; author reply 1873. PubMed ID: 17978301
    [No Abstract]   [Full Text] [Related]  

  • 15. Cetuximab-related radiation dermatitis in head-and-neck cancer patients: in regard to Studer et al. (Int J Radiat Oncol Biol Phys in press).
    Russi EG; Numico G; Merlano MC; Pinto C
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1278; author reply 1278-9. PubMed ID: 21353162
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined chemotherapy and radiotherapy. Preliminary results of clinical trial of hydroxyurea and x-irradiation in the treatment of epidermoid cancers of the head and neck.
    Lerner HJ; Beckloff GL
    Am Surg; 1967 Mar; 33(3):165-70. PubMed ID: 6019627
    [No Abstract]   [Full Text] [Related]  

  • 17. Cetuximab-induced aseptic meningitis.
    Feinstein TM; Gibson MK; Argiris A
    Ann Oncol; 2009 Sep; 20(9):1609-1610. PubMed ID: 19643807
    [No Abstract]   [Full Text] [Related]  

  • 18. A retrospective, multicenter study of the tolerance of induction chemotherapy with docetaxel, Cisplatin, and 5-Fluorouracil followed by radiotherapy with concomitant cetuximab in 46 cases of squamous cell carcinoma of the head and neck.
    Buiret G; Combe C; Favrel V; Pommier P; Martin L; Ecochard R; Fayette J; Tartas S; Ramade A; Céruse P
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):430-7. PubMed ID: 19775831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grading system and management guidelines for dermatitis induced by head and neck radiotherapy plus cetuximab: clinical validation required.
    Langendijk JA; Oosting SF
    Ann Oncol; 2011 Oct; 22(10):2157-9. PubMed ID: 21878428
    [No Abstract]   [Full Text] [Related]  

  • 20. StatBite: Radiation therapy plus cetuximab: skin reactions from 71 head and neck cancer patients from 11 institutions in Europe.
    J Natl Cancer Inst; 2010 Jan; 102(2):75. PubMed ID: 20054017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.